Historical Evolution: Methods, Attitudes, Goals

  • A. V. Pollock

Abstract

“Research” said Benjamin Jowett, the great Oxford classical scholar of the 19th century, “Research! A mere excuse for idleness, it has never achieved and will never achieve any results of the slightest value” (1).

Keywords

Placebo Dust Aspirin Tuberculosis Penicillin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sutherland J, editor. The Oxford Book of Literary Anecdotes. Oxford: Clarendon Press, 1975: 253.Google Scholar
  2. 2.
    Lâkatos I. Falsification and the methodology of scientific research programmes. In: Lakatos I, Musgrave A editors. Criticism and the growth of knowledge. Cambridge: Cambridge University 21. Press, 1970.Google Scholar
  3. 3.
    Popper K. Conjectures and refutations: the growth 22. of scientific knowledge. London: Routledge & Kegan Paul, 4th ed. 1972: 129.Google Scholar
  4. 4.
    McIntyre N, Popper K. The critical attitude in medicine: the need for a new ethics. Brit Med J 1983; 287: 1919–23.CrossRefGoogle Scholar
  5. 5.
    Corrigan DJ. Aneurysm of the aorta. Singular pulsation of the arteries-necessity of the employment of the stethescope. Lancet 1829; i: 586–90.CrossRefGoogle Scholar
  6. 6.
    Murphy TD. Medical knowledge and statistical methods in early nineteenth century France. Med Hist 1981; 25: 301–09.PubMedGoogle Scholar
  7. 7.
    Westergaard H. Contributions to the history of statistics. London: P.S. King & Son Ltd., 1932.Google Scholar
  8. 8.
    Stamp J. Quoted by: Dunea G. Swallowing the golden ball. Brit Med J 1983; 286: 1962–63.CrossRefGoogle Scholar
  9. 9.
    Gaines WJ, Langford HG. Research on the effect of blood-letting in several inflammatory maladies. Arch Intern Med 1960; 106: 571–79.PubMedCrossRefGoogle Scholar
  10. 10.
    Linton RR. Porta-caval shunts in the treatment of portal hypertension, with special reference to patients previously operated upon. New Eng J Med 1948; 238: 723–27.PubMedCrossRefGoogle Scholar
  11. 11.
    Garceau AJ, Donaldson RM, O’Hara ET, Callow AD, Muench H, Chalmers TC and the Boston Inter-Hospital Liver Group. A controlled trial of prophylactic portacaval-shunt surgery. New Eng J Med 1964; 270: 496–500.CrossRefGoogle Scholar
  12. 12.
    Normann E, Korvald E, Lotveit T. Perforated appendicitis-lavage or drainage? Ann Chir et Gynae Fenn 1975; 64: 195–97.Google Scholar
  13. 13.
    Yates F, Mather K. Ronald Aylmer Fisher 18901962. Biographical Memoirs of Fellows of the Royal Society 1963; 9: 91–129.CrossRefGoogle Scholar
  14. 14.
    Fisher RA. Statistical Methods for Research Workers. Edinburgh: Oliver & Boyd, 1925.Google Scholar
  15. 15.
    Fisher RA. The Design of Experiments. Edinburgh: Oliver & Boyd, 1935.Google Scholar
  16. 16.
    Bradford Hill A. A Short Textbook of Medical Statistics. London: Hodder & Stoughton Educational, 1977.Google Scholar
  17. 17.
    Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. A Medical Research Council investigation. Brit Med J 1948; 2: 769–82.CrossRefGoogle Scholar
  18. 18.
    Bradford Hill A. Medical ethics and controlled trials. Brit Med J 1963; 1: 1043–49.CrossRefGoogle Scholar
  19. 19.
    Epstein LC, Lasagna L. Obtaining informed consent. Arch Intern Med 1969; 123: 682–88.PubMedCrossRefGoogle Scholar
  20. 20.
    Chatterton V Gerson, The Times, 7 February 1980, per Bristow J. Quoted in: Legal correspondent, the limits of consent. Brit Med J 1983; 286: 182–83.Google Scholar
  21. 21.
    Law Report, House of Lords. The Times (London) 1985 Feb 22: 28.Google Scholar
  22. 22.
    Chalmers TC. In: Tygstrup N, Lachin JM, Juhi E, editors. The randomized clinical trial and therapeutic decisions. New York: Marcel Dekker Inc, 1982.Google Scholar
  23. 23.
    Warlow C. Is informed consent always needed? Lancet 1982; 2: 1280.PubMedCrossRefGoogle Scholar
  24. 24.
    Leaper DJ, Pollock AV, Evans M. Abdominal wound closure: a trial of nylon, polygloycolic acid and steel sutures. Brit J Surg 1977; 64: 603–06.PubMedCrossRefGoogle Scholar
  25. 25.
    Cancer research campaign working party in breast conservation. Informed consent: the ethical, legal and medical implications for doctors and patients who participate in randomized clinical trials. Brit Med J 1983; 286: 1117–21.CrossRefGoogle Scholar
  26. 26.
    Zelen M. A new design for randomized clinical trials. New Eng J Med 1979; 300: 1242–45.PubMedCrossRefGoogle Scholar
  27. 27.
    Papaioannou A. Informed consent after randomization. Lancet 1982: 828.Google Scholar
  28. 28.
    Burkhardt R, Kienle G. Controlled clinical trials and medical ethics. Lancet 1978; 2: 1356–59.CrossRefGoogle Scholar
  29. 29.
    Young RSK. Role of the FDA in cancer therapy research. Clin Oncol 1981; 8: 447–52.Google Scholar
  30. Shapiro SH, Louis TA. Clinical trials. New York: Marcel Dekker Inc, 1983.Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1986

Authors and Affiliations

  • A. V. Pollock

There are no affiliations available

Personalised recommendations